GHU Logo
The Great Heights University Library
Academic discovery, digital access, and research support

Cytotoxic Drug Resistance Mechanisms (Record no. 7723)

MARC details
000 -LEADER
fixed length control field 03722nam a22004695i 4500
001 - CONTROL NUMBER
control field 978-1-59259-687-4
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20260610083708.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 100301s1999 xxu| s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781592596874
-- 978-1-59259-687-4
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1385/1592596878
Source of number or code doi
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC254-282
072 #7 - SUBJECT CATEGORY CODE
Subject category code MJCL
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED062000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MJCL
Source thema
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.994
Edition information 23
245 10 - TITLE STATEMENT
Title Cytotoxic Drug Resistance Mechanisms
Medium [electronic resource] /
Statement of responsibility, etc. edited by Robert Brown, Uta Böger-Brown.
250 ## - EDITION STATEMENT
Edition statement 1st ed. 1999.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Totowa, NJ :
Name of producer, publisher, distributor, manufacturer Humana Press :
-- Imprint: Humana,
Date of production, publication, distribution, manufacture, or copyright notice 1999.
300 ## - online resource
Extent XI, 238 p.
Other physical details online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
347 ## - DIGITAL FILE CHARACTERISTICS
File type text file
Encoding format PDF
Source rda
490 1# - SERIES STATEMENT
Series statement Methods in Molecular Medicine,
International Standard Serial Number 1940-6037 ;
Volume/sequential designation 28
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Drug Resistance -- Cell Sensitivity Assays -- Cell Sensitivity Assays -- Cell Sensitivity Assays -- Analysis of Apoptosis in Tissue Sections -- Measurement of P-glycoprotein Function -- Measuring MDR-1 by Quantitative RT-PCR -- Microtiter Plate Technique for the Measurement of Glutathione in Fresh and Cryopreserved Lymphoblasts Using the Enzyme Recycling Method -- Measurement of Reduced Glutathione Using High-Pressure Liquid Chromatography -- Topoisomerase I and II Activity Assays -- 5-Fluorouracil Metabolizing Enzymes -- Measuring DNA Adducts by Immunoassay (ELISA) -- Measuring Drug-DNA Adducts in Individual Cells -- Measurement of Drug-Induced DNA Interstrand Crosslinking Using the Single-Cell Gel Electrophoresis (Comet) Assay -- PCR Analysis of Microsatellite Instability -- O 6-Alkylguanine-DNA Alkyltransferase Assay -- Analysis of the p53 Status of Tumors -- Bcl-2 Family Immunohistochemistry -- Genetic Analysis of Drug Resistance by Fluorescence In Situ Hybridization -- Genetic Analysis of Drug Resistance by Reverse In Situ Hybridization.
520 ## - SUMMARY, ETC.
Summary, etc. In Cytotoxic Drug Resistance Mechanisms, leading clinical and laboratory scientists describe cutting-edge methods for examining the mechanisms of cellular resistance to anticancer cytotoxics in human tumors. The protocols contain detailed instructions and extensive troubleshooting tips that allow researchers effectively to study a wide variety of drug resistance mechanisms, including aspects of drug-induced cell death, drug uptake/efflux, drug metabolism, and DNA repair. Each method is designed to help identify the correlation between molecular and biochemical data and the clinical responses of the patient. Cytotoxic Drug Resistance Mechanisms makes it possible to test established and laboratory-derived hypotheses with clinically derived tumor samples. State-of-the-art and readily reproducible, the methods presented here afford basic and clinical scientists a powerful complement of tools for investigating all the clinically relevant mechanisms used as markers of the biological response to anticancer chemotherapeutics today.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oncology.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oncology.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Brown, Robert.
Relator term editor.
Relationship edt
-- http://id.loc.gov/vocabulary/relators/edt
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Böger-Brown, Uta.
Relator term editor.
Relationship edt
-- http://id.loc.gov/vocabulary/relators/edt
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer Nature eBook
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed edition:
International Standard Book Number 9780896036031
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed edition:
International Standard Book Number 9781617370939
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed edition:
International Standard Book Number 9781489941725
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Methods in Molecular Medicine,
International Standard Serial Number 1940-6037 ;
Volume/sequential designation 28
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1385/1592596878">https://doi.org/10.1385/1592596878</a>
912 ## -
-- ZDB-2-PRO

No items available.